Related Topics


Companies




  

Company: BD Biosciences

Press releases and articles
September 09. 2010
BD to present at the 2010 Morgan Stanley Global Healthcare Conference
August 04. 2010
BD receives CLIA 'Moderate Complexity' status for the BD MAX GBS assay
August 03. 2010
BD completes sales of Ophthalmic Systems unit and surgical blades product platform
July 30. 2010
BD announces promotion of President Vince Forlenza; gains additional title of Chief Operating Officer
July 28. 2010
BD Board declares dividend
July 27. 2010
BD Board of Directors elects Christopher Jones
July 20. 2010
BD Biosciences introduces CD4 testing product that does not require refrigeration
July 08. 2010
BD announces live webcast of third fiscal quarter earnings conference call
June 22. 2010
BD and PEPFAR collaboration initiates program to improve blood-drawing practices in clinics and hospitals in Sub-Saharan Africa
June 17. 2010
BD Biosciences to fund $100,000 in stem cell research grants
June 09. 2010
BD signs agreements to Sell Ophthalmic Systems Unit, other platforms
June 08. 2010
BD launches world’s smallest pen needle
June 04. 2010
BD Biosciences announces second set of winners of expanded research grant program
June 04. 2010
BD issues 2009 sustainability report
May 26. 2010
BD Board declares dividend
May 12. 2010
BD Biosciences launches adaptable 7-laser flow cytometry system for advanced research applications
May 10. 2010
BD Biosciences launches adaptable 7-laser flow cytometry system for advanced research applications
April 15. 2010
BD Biosciences launches new BD LSRFortessa cell analyzer
March 22. 2010
BD Diagnostics launches the BD Protect infection surveillance and prevention software portfolio
February 25. 2010
BD Biosciences launches BD FACSAria(TM) III Flow Cytometry System
February 03. 2010
BD announces results of shareholder votes at annual meeting
November 25. 2009
BD Board increases dividend and authorizes additional share repurchases
November 06. 2009
BD Diagnostics launches turnkey continuing education program for clinical laboratories
November 05. 2009
BD announces results for fourth fiscal quarter and full year
October 08. 2009
BD Ranked in the top 100 greenest big companies - named again to Dow Jones Sustainability World and North America Indexes
October 07. 2009
BD announces live webcast of fourth fiscal quarter earnings conference call
October 07. 2009
BD announces FDA 510(k) clearance of BD Vacutainer Rapid Serum Blood Collection Tube
September 29. 2009
BD receives Health Canada approval for the BD FocalPoint™ GS Imaging System to enhance the detection of cervical cancer
August 19. 2009
BD Biosciences launches BDT Kaleidoscope program
August 18. 2009
BD Biosciences' reagent and dye expansion program launches with flow cytometry antibodies for cell analysis
August 14. 2009
BD Biosciences taps Ingenuity to add Pathway Maps to e-commerce site
August 07. 2009
BD adds surveillance capability to infectious disease portfolio
July 29. 2009
BD Board declares dividend
July 27. 2009
BD flu preparedness statement
July 20. 2009
Training programs in Uganda, South Africa and Mozambique improve laboratory practices, safety and patient care
July 10. 2009
BD Biosciences presents new flow cytometry-based methods for stem cell research
July 03. 2009
BD Biosciences launches new portfolio of surfaces for cell-based drug discovery screening and basic cell culture research
June 19. 2009
BD and FIND achieve milestone in global battle against MDR-TB
June 18. 2009
BD and FIND achieve milestone in global battle against MDR-TB
June 17. 2009
BD Biosciences in San Jose looks to stem cell funding to boost business
June 05. 2009
BD Biosciences launches new cell analyzer for complex multicolor experiments in disease and drug development research
May 19. 2009
BD and HandyLab announce exclusive collaboration to commercialize molecular assays
May 05. 2009
BD and Fujirebio Diagnostics sign worldwide agreement to develop biomarker assays to improve cancer detection and management
May 04. 2009
BD to present at investor healthcare conferences
April 29. 2009
BD announces results for second fiscal quarter
March 13. 2009
BD named to 100 Best Corporate Citizens List by CRO Magazine
March 13. 2009
BD becomes a member of the Safe Injection Practices Coalition, an education and awareness campaign
February 12. 2009
BD announces CE marking of BD ProbeTec™ Qx amplified assays to improve detection of Chlamydia trachomatis and Neisseria gonorrhoeae
February 04. 2009
BD announces results of the Annual Shareholders Meeting and oard declares dividend
January 29. 2009
BD announces results for first fiscal quarter